Literature DB >> 34307328

Retinal Hemangioblastoma with Extraocular Extension: Report of Three Cases.

Namita Kumari1, Sima Das1, Anirban Bhaduri2, Arpan Gandhi3.   

Abstract

Retinal hemangioblastoma (RH) is the earliest and most common clinical manifestation in Von Hippel-Lindau (VHL) disease. RH can also present in isolation without any evidence of VHL. Clinical course of RH can be stationary or progress to exudation and chronic retinal detachment requiring surgical intervention. We report 3 cases of aggressive RH with extraocular extension in young males causing painful blind eye requiring enucleation. Two of our cases were bilateral involvement and had systemic manifestations of VHL. The third patient had unilateral involvement with no systemic evidence of VHL. This manifestation of RH is rarely reported. Two of our patients with VHL had early manifestations of RH and had undergone multiple cryotherapy sessions as well as retinal detachment surgery for exudative retinal detachment. This differential should be considered in vascular lesion arising from intraocular structures especially in diagnosed patients of VHL. The cases also highlight the aggressive behaviour and long-term progression of RH in some patients despite early treatment.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Extraocular extension; Hemangioblastoma; Von Hippel-Lindau disease

Year:  2021        PMID: 34307328      PMCID: PMC8280437          DOI: 10.1159/000512173

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  8 in total

1.  Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma.

Authors:  Yujuan Wang; Mones S Abu-Asab; Defen Shen; Zhengping Zhuang; Emily Y Chew; Chi-Chao Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-24       Impact factor: 3.117

2.  Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.

Authors:  Emily Ying Chew
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.

Authors:  Mary E Aronow; Henry E Wiley; Alain Gaudric; Valerie Krivosic; Michael B Gorin; Carol L Shields; Jerry A Shields; Eric W Jonasch; Arun D Singh; Emily Y Chew
Journal:  Retina       Date:  2019-12       Impact factor: 4.256

4.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

5.  Solitary retinal capillary hemangioma: hereditary (von Hippel-Lindau disease) or nonhereditary?

Authors:  A Singh; J Shields; C Shields
Journal:  Arch Ophthalmol       Date:  2001-02

6.  Treatment of retinal capillary hemangioma.

Authors:  Arun D Singh; Mahnaz Nouri; Carol L Shields; Jerry A Shields; Noel Perez
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

7.  Scleral penetration of an unusually aggressive case of a retinal hemangioblastoma.

Authors:  Murilo Rodrigues; Nicholas T Iliff; Charles G Eberhart; Silvia Montaner; Akrit Sodhi
Journal:  Can J Ophthalmol       Date:  2013-08       Impact factor: 1.882

Review 8.  Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome.

Authors:  Sarah M Nielsen; Lindsay Rhodes; Ignacio Blanco; Wendy K Chung; Charis Eng; Eamonn R Maher; Stéphane Richard; Rachel H Giles
Journal:  J Clin Oncol       Date:  2016-04-25       Impact factor: 44.544

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.